Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd

Bullboard Posts

Comment by Fundy13on Dec 11, 2018 1:40pm

91 Views

Post# 29098304

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:THERAPIX UPDATE TODAY

$48million US at $0.30 CDN per share would mean HUGE is issuing 210million shares to make the deal happen. At this point I do not think that will happen. I would love it if it did, as a TRPX shareholder, but if HUGE is looking to change the terms of the LOI they either have to be looking to lower the $48million or they have to be looking to use a SP for HUGE that is based on a moving average from the past, like a 40 day average from the 50 day prior to the announcement of the definitive agreement, which would allow them to issue shares at a value of about $0.40 and accomplish the same thing.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles